University Network

The anabolic agent, Teriparatide, has received a boost in status as a preferentially effective treatment for glucocorticoid-induced osteoporosis in the form of a second, confirmatory, randomized double-blind trial.
The drug achieves substantially greater increases in bone mineral density compared to a bisphosphonate, according to the trial.
From Familypracticenews.com:

“Based upon the pathogenesis of glucocorticoid-induced osteoporosis [...]

Teriparatide, a synthetic form of the human parathyroid hormone can be used to treat glucocorticoid-induced osteoporosis (OP), as per a recent study.
It was found by the involved researchers that patients with glucocorticoid-induced osteoporosis and administered with teriparatide for a period of 36 months displayed a higher increase in the level of bone mineral density and [...]

Steroid induced osteoporosis is common among patients under the maintenance of drugs such as prednisone, prednisolone, dexamethasone and cortisone. These types of steroids are called glucocorticoids. These hormones are created naturally by the body to facilitate decrease in inflammation among patients with autoimmune disease. Patients with lupus, rheumatoid arthritis, Crohn’s disease and asthma commonly take [...]

General Practioners are encouraged to initially discuss the potential risks of inhaled-steroids to Chronic Obstructive Pulmonary Disease or COPD patients. This is in relation to the recent study which directly links inhaled corticosteroids to pneumonia, osteoporosis and adrenal suppression.
According to Dr John Haughney of the General Practice Airways Group, GPs should explain the potential risks [...]